Secretory expression of Par-4 SAC-HA2TAT following adeno-associated virus-mediated gene transfer induces apoptosis in HepG2 cells.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Medicine Reports

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2010.343PMID 21472309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TAT‐mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression

  2009cited by this paper
• Par-4 is an essential downstream target of DAP-like kinase (Dlk) in Dlk/Par-4-mediated apoptosis.

  2009cited by this paper
• Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase.

  2008cited by this paper
• Comparative study on transduction and toxicity of protein transduction domains

  2008cited by this paper
• Par-4 binds to topoisomerase 1 and attenuates its DNA relaxation activity.

  2008cited by this paper
• Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide.

  2007cited by this paper
• Cancer resistance in transgenic mice expressing the SAC module of Par-4.

  2007cited by this paper
• Inactivation of the candidate tumor suppressor par-4 in endometrial cancer.

  2007cited by this paper
• Advances in fluorescent protein technology

  2007cited by this paper
• The taming of the cell penetrating domain of the HIV Tat: myths and realities.

  2007cited by this paper
• Tumour‐suppression activity of the proapoptotic regulator Par4

  2005cited by this paper
• Par-4-mediated recruitment of Amida to the actin cytoskeleton leads to the induction of apoptosis.

  2005cited by this paper
• Par‐4 inducible apoptosis in prostate cancer cells

  2004cited by this paper
• Apoptosis in prostate cancer: progressive and therapeutic implications (Review).

  2004cited by this paper
• Anti-liver cancer activity of TNF-related apoptosis-inducing ligand gene and its bystander effects.

  2004cited by this paper
• Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis

  2004cited by this paper
• Apoptosis by Par-4 in cancer and neurodegenerative diseases.

  2003cited by this paper
• Identification of a Unique Core Domain of Par-4 Sufficient for Selective Apoptosis Induction in Cancer Cells

  2003cited by this paper
• Par-4 Transcriptionally Regulates Bcl-2 through a WT1-binding Site on the bcl-2 Promoter*

  2003cited by this paper
• Recombinant adeno-associated virus vectors efficiently transduce foreign gene into bovine aortic endothelial cells: comparison with adenovirus vectors.

  2000cited by this paper

• Prostate apoptosis response-4 and tumor suppression: it’s not just about apoptosis anymore

  2021cites this paper
• Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer cells

  2020cites this paper
• Intranasal Delivery of Recombinant AAV Containing BDNF Fused with HA2TAT: a Potential Promising Therapy Strategy for Major Depressive Disorder

  2016cites this paper
• A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4

  2016cites this paper
• Adeno-associated virus-mediated cancer gene therapy: current status.

  2015cites this paper
• Off-on polyadenylation strategy as a supplemental mechanism for silencing toxic transgene expression during lentiviral vector production.

  2014cites this paper
• Par-4 as a potential target for cancer therapy

  2013cites this paper